Experienced in Lung Metastases

Thomas Zilli

Geneve, GE, CH 
Experienced in Lung Metastases
Geneve, GE, CH 
OverviewLocationsClinical Research

Overview

Thomas Zilli practices in Geneve, Switzerland. Mr. Zilli is rated as an Experienced expert by MediFind in the treatment of Lung Metastases. His top areas of expertise are Prostate Cancer, Anal Cancer, Colorectal Cancer, Prostatectomy, and Cystectomy.

His clinical research consists of co-authoring 225 peer reviewed articles and participating in 5 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 2 articles in the study of Lung Metastases.

Gender
Male

Locations

Geneve, GE 1206, Switzerland
Other Locations
Bellinzona, TI, Switzerland
Lugano, TI, Switzerland
Luzerner Kantonsspital
Luzern, LU, Switzerland
Kantonsspital Aarau
Aarau, AG, Switzerland
Switzerland
CHU Vaudois
Lausanne, VD, Switzerland
St. Gallen
Kantonsspital St. Gallen, Switzerland

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

Effect of Low Dose Radiotherapy on Brain Amyloidosis in the Treatment of Alzheimer's Disease: a Randomized Pilot Study
Effect of Low Dose Radiotherapy on Brain Amyloidosis in the Treatment of Alzheimer's Disease: a Randomized Pilot Study
Enrollment Status: Active_not_recruiting
Publish Date: January 09, 2025
Intervention Type: Radiation
Study Phase: Not Applicable
Phase IIIb Randomized Trial Comparing Irradiation Plus Long Term Adjuvant Androgen Deprivation With GnRH Antagonist Versus GnRH Agonist Plus Flare Protection in Patients With Very High Risk Localized or Locally Advanced Prostate Cancer. A Joint Study of the EORTC ROG and GUCG
Phase IIIb Randomized Trial Comparing Irradiation Plus Long Term Adjuvant Androgen Deprivation With GnRH Antagonist Versus GnRH Agonist Plus Flare Protection in Patients With Very High Risk Localized or Locally Advanced Prostate Cancer. A Joint Study of the EORTC ROG and GUCG
Enrollment Status: Active_not_recruiting
Publish Date: November 05, 2024
Intervention Type: Drug, Radiation
Study Drugs: Degarelix, GnRH agonist
Study Phase: Phase 3
Prospective Cohort Study With Collection of Clinical Data, Serum and Plasma of Patients With Prostate Disease
Prospective Cohort Study With Collection of Clinical Data, Serum and Plasma of Patients With Prostate Disease
Enrollment Status: Active_not_recruiting
Publish Date: June 08, 2022
Intervention Type: Other
SAKK 08/15 - PROMET - Multicenter, Randomized Phase II Trial of Salvage Radiotherapy +/- Metformin for Patients With Prostate Cancer After Prostatectomy
SAKK 08/15 - PROMET - Multicenter, Randomized Phase II Trial of Salvage Radiotherapy +/- Metformin for Patients With Prostate Cancer After Prostatectomy
Enrollment Status: Terminated
Publish Date: April 14, 2022
Intervention Type: Radiation, Drug
Study Drug: Metformin
Study Phase: Phase 2
Radiotherapy and 6-month Androgen Deprivation Therapy With or Without Apalutamide in Intermediate and Limited High Risk Localized Prostate Cancer: a Phase III Study
Radiotherapy and 6-month Androgen Deprivation Therapy With or Without Apalutamide in Intermediate and Limited High Risk Localized Prostate Cancer: a Phase III Study
Enrollment Status: Withdrawn
Publish Date: August 17, 2020
Intervention Type: Drug, Other
Study Phase: Phase 3
View 4 Less Clinical Trials

225 Total Publications

Urinary organs-at-risk for radiotherapy following radical prostatectomy: contouring guidelines on behalf of the Francophone Group of Urological Radiation Therapy (GFRU).
Urinary organs-at-risk for radiotherapy following radical prostatectomy: contouring guidelines on behalf of the Francophone Group of Urological Radiation Therapy (GFRU).
Journal: Practical radiation oncology
Published: July 16, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Zilli's expertise for a condition
ConditionClose
View All 26 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile